Blog

Promising news regarding new treatment for patients with malignant pleural mesothelioma emerges with the release of two immunotherapy drugs, Keytruda and Opdivo. Keytruda (pembrolizumab) is a product of Merck & Co. and Opdivo (nivolumab) is created by Bristol-Myers Squibb. These drugs have recently been approved by the FDA to be used in fighting non-small cell » Read More

On October 30, 2015, the Cannon House Office building in Washington DC was evacuated upon learning that there had potentially been an asbestos leak. The Architect of the Capitol (AOC) confirmed that an asbestos leak had in fact occurred during the recent construction that was a part of the Cannon Renewal Project. Since then, the » Read More

A recent court ruling in California’s Court of Appeal may have just changed the way mesothelioma cases are won. In Schiffer v. CBS, the plaintiff claimed he was exposed to asbestos containing materials during installation of equipment and insulation manufactured by Westinghouse, CBS Corporation’s predecessor in 1969. Details of the Case James Schiffer, the Plaintiff, » Read More

Mesothelioma is an unusual health condition insofar as it affects humans as well as other mammals. Mesothelioma is an aggressive type of cancer caused by airborne asbestos exposure. Although mesothelioma in pets is uncommon, it does occur. There is no cure for malignant mesothelioma (in pets or in humans), and due to the nature of » Read More